RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 916-926

  Wang, Qi ^a   Wang, Jun Yu ^a   Zhang, Xiao Ping ^b,c   Lv, Zhong Wei ^b   Fu, Da ^c   Lu, Yi Cheng ^a   Hu, Guo Han ^a   Luo, Chun ^a   Chen, Ju Xiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN RLIP76; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P53; RAC1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; UBIQUITINATION;

ANIMALS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GLIOBLASTOMA; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KI-67 ANTIGEN; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM TRANSPLANTATION; PROGNOSIS; RAC1 GTP-BINDING PROTEIN; RATS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84875947010     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs401     Document Type: Article

References (44)

1. Avgeropoulos,N.G. et al. (1999) New treatment strategies for malignant gliomas. Oncologist, 4, 209-224.
2. Stupp,R. et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 352, 987-996.
3. Wen,P.Y. et al. (2008) Malignant gliomas in adults. N. Engl. J. Med., 359, 492-507.
4. Van Meir,E.G. et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin., 60, 166-193.
5. Awasthi,S. et al. (2000) Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry, 39, 9327-9334.
6. Awasthi,S. et al. (2003) Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int. J. Cancer, 106, 635-646.
7. Awasthi,S. et al. (2003) Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. Int. J. Oncol., 22, 713-720.
8. Awasthi,S. et al. (1998) ATP-dependent human erythrocyte glutathioneconjugate transporter. I. Purification, photoaffinity labeling, and kinetic characteristics of ATPase activity. Biochemistry, 37, 5231-5238.
9. Awasthi,S. et al. (1994) Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J. Clin. Invest., 93, 958-965.
10. Singhal,S.S. et al. (2003) Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells. Int. J. Oncol., 22, 365-375.
11. Stuckler,D. et al. (2005) RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Res., 65, 991-998.
12. Yadav,S. et al. (2005) POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochem. Biophys. Res. Commun., 328, 1003-1009.
13. Quaroni,A. et al. (1999) Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J. Cell Sci., 112 (Pt 5), 707-718.
14. Rosse,C. et al. (2003) RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J. Biol. Chem., 278, 30597-30604.
15. Awasthi,S. et al. (2003) Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int. J. Oncol., 22, 721-732.
16. Margutti,P. et al. (2008) Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immunemediated vascular diseases and atherosclerosis. Blood, 111, 4559-4570.
17. Hu,Y. et al. (2003) HSF-1 interacts with Ral-binding protein 1 in a stressresponsive, multiprotein complex with HSP90 in vivo. J. Biol. Chem., 278, 17299-17306.
18. Park,S.H. et al. (1995) A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene, 11, 2349-2355.
19. Singhal,S.S. et al. (2006) Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res., 66, 2354-2360.
20. Singhal,S.S. et al. (2007) Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res., 67, 4382-4389.
21. Cheng,J.Z. et al. (2001) Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J. Biol. Chem., 276, 41213-41223.
22. Cantor,S.B. et al. (1995) Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol., 15, 4578-4584.
23. Jullien-Flores,V. et al. (1995) Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem., 270, 22473-22477.
24. Senger,D.L. et al. (2002) Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes. Cancer Res., 62, 2131-2140.
25. Bos,J.L. et al. (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell, 129, 865-877.
26. Pop,M. et al. (2004) Isotype-specific degradation of Rac activated by the cytotoxic necrotizing factor 1. J. Biol. Chem., 279, 35840-35848.
27. Lynch,E.A. et al. (2006) Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol. Biol. Cell, 17, 2236-2242.
28. Wang,J. et al. (2012) Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J. Neurooncol., 106, 473-484.
29. Neel,N.F. et al. (2012) The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector. Mol. Cell. Biol., 32, 1374-1386.
30. Boissel,L. et al. (2007) Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation. Dev. Biol., 312, 331-343.
31. Murray,N.R. et al. (2004) Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J. Cell Biol., 164, 797-802.
32. Stallings-Mann,M. et al. (2006) A novel small-molecule inhibitor of protein kinase Cι blocks transformed growth of non-small-cell lung cancer cells. Cancer Res., 66, 1767-1774.
33. Pscherer,A. et al. (2006) Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma. FASEB J., 20, 1188-1190.
34. Nawrocki,S.T. et al. (2005) Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res., 65, 11658-11666.
35. Paxinos,G. et al. (1998) The Rat Brain in Stereotaxic Coordinates. 4th edn. Academic Press, San Diego, CA.
36. Colen,C.B. et al. (2011) Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia, 13, 620-632.
37. Calcagno,S.R. et al. (2008) Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int. J. Cancer, 122, 2462-2470.
38. Singhal,S.S. et al. (2009) Regression of prostate cancer xenografts by RLIP76 depletion. Biochem. Pharmacol., 77, 1074-1083.
39. Nakashima,A. et al. (2008) RACK1 functions in rice innate immunity by interacting with the Rac1 immune complex. Plant Cell, 20, 2265-2279.
40. Singhal,J. et al. (2011) Targeting p53-null neuroblastomas through RLIP76. Cancer Prev. Res. (Phila.), 4, 879-889.
41. Singhal,S.S. et al. (2009) RLIP76: a target for kidney cancer therapy. Cancer Res., 69, 4244-4251.
42. Neel,N.F. et al. (2012) The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector. Mol. Cell. Biol., 32, 1374-1386.
43. Awasthi,S. et al. (2001) Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences. Biochemistry, 40, 4159-4168.
44. Boissel,L. et al. (2007) Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation. Dev. Biol., 312, 331-343.